Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.47M 19.35M 17.57M 32.93M 2.27B 33.12M 231M 89.26M 1.15B 88.75M 86.78M 3.66B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.56M 34.55M 31.37M 58.79M 4.05B 59.14M 412M 159M 2.05B 158M 155M 6.54B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
04/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
15/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
13/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
13/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
04/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
01/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
12/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 week+100.00%
Current month+61.54%
1 month+100.00%
3 months-19.23%
6 months+5.00%
Current year+27.27%
1 week 0
Extreme 0.0021
0
1 month 0
Extreme 0.0011
0
Current year 0
Extreme 0.0011
0.01
1 year 0
Extreme 0.0011
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+100.00%-40.00%+281.82% 839K
+0.53%-8.17%-37.99%-53.86% 1.75B
+0.94%-5.98% - - 1.52B
+1.92%+3.11%-23.21%+153.16% 1.15B
-0.13%-3.14%-47.34%+13.20% 1.09B
-0.21%-2.01%+216.09%+907.63% 1.05B
+1.10%+0.04%+48.63%+34.66% 969M
+2.86%+5.70%+21.38%+188.90% 798M
+1.22%-11.81%-21.94%+45.95% 716M
+3.10%-5.86%+32.60%-23.42% 523M
Average +1.13%-2.22%+16.47%+172.00% 956.71M
Weighted average by Cap. +1.05%-3.23%+18.41%+156.19%

Financials

2015 2016
Net sales 25.48M 22.08M 20.87M 18.95M 35.51M 2.44B 35.72M 249M 96.28M 1.24B 95.72M 93.59M 3.95B 32.33M 28.02M 26.48M 24.04M 45.06M 3.1B 45.33M 316M 122M 1.57B 121M 119M 5.01B
Net income 5.49M 4.76M 4.5M 4.09M 7.66M 527M 7.7M 53.73M 20.76M 267M 20.64M 20.18M 852M 2.06M 1.79M 1.69M 1.53M 2.87M 198M 2.89M 20.16M 7.79M 100M 7.74M 7.57M 320M
Net Debt 24.8M 21.5M 20.32M 18.44M 34.57M 2.38B 34.78M 243M 93.72M 1.21B 93.18M 91.11M 3.85B 18.56M 16.08M 15.2M 13.8M 25.87M 1.78B 26.02M 181M 70.13M 903M 69.72M 68.17M 2.88B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
16/09/26 US$0.002200 -48.84% 700
14/09/26 US$0.004300 +104.76% 3,750
  1. Stock Market
  2. Stocks
  3. AOXG Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!